Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2010

Open Access 01-12-2010 | Review

Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society

Authors: Antonio C Lerario, Antonio R Chacra, Augusto Pimazoni-Netto, Domingos Malerbi, Jorge L Gross, José EP Oliveira, Marilia B Gomes, Raul D Santos, Reine MC Fonseca, Roberto Betti, Roberto Raduan

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Login to get access

Abstract

The Brazilian Diabetes Society is starting an innovative project of quantitative assessment of medical arguments of and implementing a new way of elaborating SBD Position Statements. The final aim of this particular project is to propose a new Brazilian algorithm for the treatment of type 2 diabetes, based on the opinions of endocrinologists surveyed from a poll conducted on the Brazilian Diabetes Society website regarding the latest algorithm proposed by American Diabetes Association /European Association for the Study of Diabetes, published in January 2009.
An additional source used, as a basis for the new algorithm, was to assess the acceptability of controversial arguments published in international literature, through a panel of renowned Brazilian specialists. Thirty controversial arguments in diabetes have been selected with their respective references, where each argument was assessed and scored according to its acceptability level and personal conviction of each member of the evaluation panel.
This methodology was adapted using a similar approach to the one adopted in the recent position statement by the American College of Cardiology on coronary revascularization, of which not only cardiologists took part, but also specialists of other related areas.
Appendix
Available only for authorised users
Literature
3.
go back to reference Grupo Interdisciplinar de Padronização da Hemoglobina Glicada - A1C: Atualização sobre Hemoglobina Glicada (A1C) para Avaliação do Controle Glicêmico e para o Diagnóstico do Diabetes: Aspectos Clínicos e Laboratoriais. Posicionamento Oficial 3ª Edição. Brazilian Diabetes Society, Brazilian Endocrinology and Metabolim Society, Brazilian Clinical and Pathology Society, National Diabetes Federation. 2009 Grupo Interdisciplinar de Padronização da Hemoglobina Glicada - A1C: Atualização sobre Hemoglobina Glicada (A1C) para Avaliação do Controle Glicêmico e para o Diagnóstico do Diabetes: Aspectos Clínicos e Laboratoriais. Posicionamento Oficial 3ª Edição. Brazilian Diabetes Society, Brazilian Endocrinology and Metabolim Society, Brazilian Clinical and Pathology Society, National Diabetes Federation. 2009
4.
go back to reference American Diabetes Association: Standards of Medical Care in Diabetes - 2009. Diabetes Care. 2010, 32 (Suppl 1): S16-S61. American Diabetes Association: Standards of Medical Care in Diabetes - 2009. Diabetes Care. 2010, 32 (Suppl 1): S16-S61.
5.
go back to reference Pignone M: Decisions about intensity of glycemic control should depend on age and functional status. Clinical Diabetes. 2009, 27: 147-8. 10.2337/diaclin.27.4.147.CrossRef Pignone M: Decisions about intensity of glycemic control should depend on age and functional status. Clinical Diabetes. 2009, 27: 147-8. 10.2337/diaclin.27.4.147.CrossRef
9.
10.
go back to reference Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber A, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schartz SS: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on type 2 diabetes mellitus:an algorithm for glycemic control. Endocrine Practice. 2009, 15: 540-559.CrossRefPubMed Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber A, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schartz SS: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on type 2 diabetes mellitus:an algorithm for glycemic control. Endocrine Practice. 2009, 15: 540-559.CrossRefPubMed
11.
go back to reference Grant RW: How Doctors Choose Medications to Treat T2DM. Diabetes Care. 2007, 30: 1448-1453. 10.2337/dc06-2499.CrossRefPubMed Grant RW: How Doctors Choose Medications to Treat T2DM. Diabetes Care. 2007, 30: 1448-1453. 10.2337/dc06-2499.CrossRefPubMed
12.
go back to reference Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care. 2009, 32: 193-20. 10.2337/dc08-9025.PubMedCentralCrossRefPubMed Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care. 2009, 32: 193-20. 10.2337/dc08-9025.PubMedCentralCrossRefPubMed
13.
go back to reference Matveyenko AV, Dry S, Cox HI, Moshtahian A, Gurlo T, Galasso R, Butler AE, Butler PC: Beneficial endocrine but adverse exocrine effects of sitaglipitinin the HIP rat model of type 2 diabetes, interactions with metformin. Diabetes. 2008, 58: 1604-1615. 10.2337/db09-0058.CrossRef Matveyenko AV, Dry S, Cox HI, Moshtahian A, Gurlo T, Galasso R, Butler AE, Butler PC: Beneficial endocrine but adverse exocrine effects of sitaglipitinin the HIP rat model of type 2 diabetes, interactions with metformin. Diabetes. 2008, 58: 1604-1615. 10.2337/db09-0058.CrossRef
14.
go back to reference Nachani JS, Bulchadani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Weide L, Alba LM: Biochemical and histological effects of exendin-4(exenatide) on the rat pancreas. Diabetologia. 2010, 53: 153-159. 10.1007/s00125-009-1515-4.CrossRef Nachani JS, Bulchadani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Weide L, Alba LM: Biochemical and histological effects of exendin-4(exenatide) on the rat pancreas. Diabetologia. 2010, 53: 153-159. 10.1007/s00125-009-1515-4.CrossRef
15.
go back to reference McMahon GT, Dlhy RG: Intention to Treat -- Initiating Insulin and the 4-T Study. N Engl J Med. 2000, 357 (17): 1759-61. 10.1056/NEJMe078196. 17CrossRef McMahon GT, Dlhy RG: Intention to Treat -- Initiating Insulin and the 4-T Study. N Engl J Med. 2000, 357 (17): 1759-61. 10.1056/NEJMe078196. 17CrossRef
16.
go back to reference Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW Sawicki PT: Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia. 2009, 52: 1732-44. 10.1007/s00125-009-1418-4.PubMedCentralCrossRefPubMed Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, Selke GW Sawicki PT: Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia. 2009, 52: 1732-44. 10.1007/s00125-009-1418-4.PubMedCentralCrossRefPubMed
17.
go back to reference Deyo JP;, Ramsey RA: Evidence-Based Clinical Practice: Concepts and Approaches. 2000, Butterworth-Heinemann. Boston, USA Deyo JP;, Ramsey RA: Evidence-Based Clinical Practice: Concepts and Approaches. 2000, Butterworth-Heinemann. Boston, USA
Metadata
Title
Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
Authors
Antonio C Lerario
Antonio R Chacra
Augusto Pimazoni-Netto
Domingos Malerbi
Jorge L Gross
José EP Oliveira
Marilia B Gomes
Raul D Santos
Reine MC Fonseca
Roberto Betti
Roberto Raduan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-2-35

Other articles of this Issue 1/2010

Diabetology & Metabolic Syndrome 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.